Self-expanding stent for transradial peripheral procedures gains FDA approval
Click Here to Manage Email Alerts
Cordis announced the FDA has approved its self-expanding vascular stent designed for transradial peripheral procedures in the iliac and superficial femoral arteries.
The self-expanding stent (S.M.A.R.T. Radianz) is part of the company’s peripheral system that includes a guiding sheath (Brite Tip Radianz) and percutaneous transluminal angioplasty catheter (Saberx Radianz), according to a press release from the company.
According to the release, 1-year revascularization rates were similar between the self-expanding stent and a drug-coated stent, and the self-expanding stent was associated with lower cost of hospitalization.
The self-expanding stent is available in a broad size matrix to support iliac and superficial femoral arteries lesion treatment, according to the release.
"We have been constrained in the greater utilization of this important access site associated with greater patient comfort and less major bleeding as our diagnostic and interventional tools that can be delivered via this access have been limited. These lower profile devices should expand the utilization of radial access in treating patients,” Craig M. Walker, MD, president and founder of the Cardiovascular Institute of the South, said in the release.
Collapse
Read more about
Click Here to Manage Email Alerts